Cargando…
Expression of ICOSL is associated with decreased survival in invasive breast cancer
BACKGROUND: Inducible co-stimulator (ICOS) is a CD28-related molecule exclusively expressed on activated T cells and plays a critical role in modulating the immune response in breast cancer. The blockage of ICOS pathway has been shown to inhibit the activity of Type 2 T helper cells, thus potentiall...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526018/ https://www.ncbi.nlm.nih.gov/pubmed/31143539 http://dx.doi.org/10.7717/peerj.6903 |